超微补阳还五汤对局灶性脑缺血模型大鼠神经元保护效应及机制研究
|
摘要
背景:缺血性脑血管病是临床常见病、多发病,有病死率高、致残率高的特点,脑缺血后神经元损害是其病理机制的核心部分,因而探寻神经元保护剂是缺血性脑血管病的研究热点。补阳还五汤是治疗该类疾病的常用方剂之一,对缺血性脑血管病的治疗具有显著疗效和一定特色。
目的:
(1)通过对超微补阳还五汤与传统补阳还五汤的有效成分的对比研究,探讨超微复方制剂的特点,为中药新型饮片的研制作出有益的探索。
(2)在建立局灶性脑缺血大鼠模型基础上,通过动物实验,探讨超微补阳还五汤对局灶性脑缺血大鼠神经元损伤的保护作用及其机制,为治疗脑梗塞的临床用药提供实验依据。
方法:
(1)采用一系列试验对超微补阳还五汤与传统汤剂的有效成分进行对比研究。对当归、赤芍、川芎、红花、桃仁的主要有效成分进行薄层鉴别研究,并对主要成分进行含量测定;采用《中国药典》收录的相关方法检测重金属、砷盐含量以明确其安全性;对水溶性浸出物和正丁醇浸出物进行含量测定对比研究。
(2)采用栓线法复制MCAO大鼠模型,随机分成六组灌胃给药;在1天、3天、7天、14天四个时点观察各相应指标以探求超微补阳还五汤对脑缺血神经元损伤的保护作用及机制。对大鼠脑缺血损伤的保护作用选用行为学变化及组织形态学变化等指标,从对氧自由基的影响对其进行验证;对作用机制的探求从NGF及其受体(TRKA)的表达和信号转导机制(PI3K/PKB)两个方面进行。具体方法则为检测血浆SOD、MDA的活性变化,用免疫组化法和分子生物学方法观察对脑组织中NGF、TRKA及PI3K、CREB、AKT的表达的影响。
结果:
(1)TLC测定各组供试样品在色谱相应的位置上,显相同颜色的斑点,且复方超微补阳还五汤浸泡液中主要有效成分斑点较传统汤剂更明显,清晰;对其主要成分的含量测定显示超微补阳还五汤中黄芪甲苷含量与传统汤剂相当;对砷盐、重金属检测未发现其含量超标;对浸出物的测定显示超微补阳还五汤水溶性浸出物为传统汤剂水溶性浸出物的1.22倍,正丁醇浸出物为其传统汤剂的1.26倍,均高于传统汤剂。
(2)超微补阳还五汤可降低脑缺血损伤大鼠神经功能评分,并改善脑组织缺血的病理损伤,其作用明显优于模型组及假手术组;超微高剂量组作用优于传统汤剂组。
(3)超微补阳还五汤可提高脑缺血后血中SOD活性并降低MDA,其作用明显优于模型组及假手术组;超微高剂量组作用优于传统汤剂组。
(4)超微补阳还五汤可上调脑缺血后脑组织NGF及其受体TRKA的表达,并增强PI3K/AKT信号转导的表达,其作用明显优于模型组及假手术组;超微高剂量组与传统汤剂比较其影响有明显增高的优势。
结论:
(1)补阳还五汤及其超微制剂可以改善局灶性脑缺血大鼠神经功能缺损评分及脑组织病理变化,提高脑缺血后血液SOD活性并降低MDA活性以减弱氧自由基的毒性反应,对脑缺血神经元损伤具有保护作用。
(2)超微补阳还五汤保持了传统补阳还五汤中的有效成分,且有效成分的溶出相对传统汤剂更具优势。
(3)超微补阳还五汤可提高脑缺血后脑组织神经营养因子PI3K/PKB信号转导途径的表达,提高神经生长因子及其受体表达水平,这可能是超微补阳还五汤对脑缺血神经元损伤的保护作用机制之一。
(4)超微补阳还五汤以1/2等效剂量时即可达与传统汤剂相同的作用效果,以等效剂量时其作用效应有明显增加的趋势。
综上,本论文采用药物化学、药理学方法以及免疫组化、分子生物学方法,以超微技术对补阳还五汤复方制剂与传统补阳还五汤标准汤剂进行对照研究,论证了超微技术在促进中药复方制剂(补阳还五汤)有效成分溶出上的优势,并从神经营养因子通路(即信号转导机制)角度揭示了超微补阳还五汤的作用机制,具有显著的创新性。
Foreword: Ischemia stroke is a frequent and common disease with high mortality and high disability in clinical work. The study show that neuronal injury following cerebral ischemia is the main part of pathological mechanism's study. So the searching of drugs for protect cerebral ischemia neuronal injury is a hotspot in this domain. BuYangHuanWu is one of the medicament with positive curative effect and obvious trait for Ischemia stroke.
Objective:
(1) Investigate the trait of the ChaoWei-BuYangHuanWu by contrasting the main effective element in ChaoWei-BuYangHuanWu and BuYangHuanWu, make some rewarding work for the medicament reform of Chinese traditional medicine.
(2) Study the effection of protecting the neuronal injury following cerebral ischemia , and make sure the mechanism by the experimentation in MCAO rat. Offering some experience for the clinical work on Ischemia stroke.
Methods:
(1) Make sure the effective element of ChaoWei-BuYangHuanWu by series test: Study the essential element of Chinese angelica Root, Red Peony Bark, Chuangxiong Rhizome, Safflower and Peach Kernal by TLC; and measure the content of the main useful element in ChaoWei-BuYangHuanWu; Make sure the content of specifically metal , complex and water-solubility- lixivium \alc-ohol-solubility-lixivium by the ways which was recorded by PharMCAOpoeia Of People's Republic Of China.
(2)Make MCAO rats by special ways, divide the rats to 6 group; and abserve the rats at 1\ 4\ 7 and 14 days, observe and record the given symptoms, give the grade by the symptoms; after the test, kill the rats and take blood , then detect the actives of SOD and MDA in blood by given ways ; after all, take the brain , Immunohistochemical avidin-biotin peroxidase complex method was applied to detect the expression of NGF and his Receptor TRKA; And In Situ Hybridization with Nick-Translated Probes was applied to detect the PI3K/PKB, which was the main Intracellular signal transduction of NGF.
RESULTS:
(1) showing the same color spot in the corresponding place on the chromato-gram of each sample of the two groups measured by TLC, and the spot is more distinctive in the effective element of ChaoWei-BuYangHuanWu.It is showed that the content of Astragaloside IV in ChaoWei-BuYangHuanWu is equivalent in the traditional decoction, the content of arsenide and specifically metal is not in superscale. It is found that the water-solubility- lixivium is 1.22 times and the alcohol-solubility-lixivium is 1.26 times in ChaoWei-BuYangHuanWu than in the traditional decoction.
(2) ChaoWei-BuYangHuanWu can reduce the grade of the the neuronal injury following cerebral ischemia, improve the pathological injury of cerebral ischemia. It is statistically different than the model group and artificial operation group, the effection of high dosage ChaoWei-BuYangHuanWu is statisti- cally better than traditional decoction.
(3 ) ChaoWei-BuYangHuanWu can improve the active function of SOD, reduce the active function of MDA. This function is statistically different than the model group and artificial operation group, the effection of high dosage ChaoWei-BuYangHuanWu is statistically better than traditional decoction.
(4) ChaoWei-BuYangHuanWu can raise the expression of NGF and his Receptor TRKA after cerebral ischemia, and boost up the signal transduction of PI3K/AKT.This function is statistically different than the model group and artificial operation group, the effection of high dosage ChaoWei-BuYangHuan Wu is statistically better than traditional decoction.
CONCLUSION:
(1) BuYangHuanWu decoction and it's ChaoWei-preparation can improve the neuronal function grades and pathological changes of rats with partial cerebral ischemia;It can improve the active function of SOD, reduce the active function of MDA to weaken the toxic of superoxide free radicals. It is protective to the injuried neurocyte of cerebral ischemia.
(2) ChaoWei-BuYangHuanWu kept the effctive element, as well as the traditional decoction and it is better than the traditional decoction in solubility -lixivium.
(3) ChaoWei-BuYangHuanWu can boost up the signal transduction of PI3K/ PKB that is a kind of Neurotrophic factor. It also can raise the expression of NGF and his Receptor TRKA after cerebral ischemia. This is likely to be one of the protective mechanism of ChaoWei-BuYangHuanWu to neuronal injury following cerebral ischemia.
(4) 1/2 equivalent effective dosage of ChaoWei-BuYangHuanWu can make the same effecion of the traditional decoction. It is prone to be effective stronger when used the equivalent effective dosage.
Above all, this topic adopted Pharmaceutical method, method of pharMCAOlogy, Immunohistochemical method and molecular organism, demonstrated the asc- endancy of promoting solubility-lixivium of effective element in traditional Chinese medicine (BuYangHuanWu decoction) by contrasting ChaoWei-BuY- angHuanWu in which ultramicro technology was used and traditional BuYang- HuanWu decoction, and revealed the mechanism of action in the view of signal transduction of Neurotrophic factor. So this topic had great new ideas.
目的:
(1)通过对超微补阳还五汤与传统补阳还五汤的有效成分的对比研究,探讨超微复方制剂的特点,为中药新型饮片的研制作出有益的探索。
(2)在建立局灶性脑缺血大鼠模型基础上,通过动物实验,探讨超微补阳还五汤对局灶性脑缺血大鼠神经元损伤的保护作用及其机制,为治疗脑梗塞的临床用药提供实验依据。
方法:
(1)采用一系列试验对超微补阳还五汤与传统汤剂的有效成分进行对比研究。对当归、赤芍、川芎、红花、桃仁的主要有效成分进行薄层鉴别研究,并对主要成分进行含量测定;采用《中国药典》收录的相关方法检测重金属、砷盐含量以明确其安全性;对水溶性浸出物和正丁醇浸出物进行含量测定对比研究。
(2)采用栓线法复制MCAO大鼠模型,随机分成六组灌胃给药;在1天、3天、7天、14天四个时点观察各相应指标以探求超微补阳还五汤对脑缺血神经元损伤的保护作用及机制。对大鼠脑缺血损伤的保护作用选用行为学变化及组织形态学变化等指标,从对氧自由基的影响对其进行验证;对作用机制的探求从NGF及其受体(TRKA)的表达和信号转导机制(PI3K/PKB)两个方面进行。具体方法则为检测血浆SOD、MDA的活性变化,用免疫组化法和分子生物学方法观察对脑组织中NGF、TRKA及PI3K、CREB、AKT的表达的影响。
结果:
(1)TLC测定各组供试样品在色谱相应的位置上,显相同颜色的斑点,且复方超微补阳还五汤浸泡液中主要有效成分斑点较传统汤剂更明显,清晰;对其主要成分的含量测定显示超微补阳还五汤中黄芪甲苷含量与传统汤剂相当;对砷盐、重金属检测未发现其含量超标;对浸出物的测定显示超微补阳还五汤水溶性浸出物为传统汤剂水溶性浸出物的1.22倍,正丁醇浸出物为其传统汤剂的1.26倍,均高于传统汤剂。
(2)超微补阳还五汤可降低脑缺血损伤大鼠神经功能评分,并改善脑组织缺血的病理损伤,其作用明显优于模型组及假手术组;超微高剂量组作用优于传统汤剂组。
(3)超微补阳还五汤可提高脑缺血后血中SOD活性并降低MDA,其作用明显优于模型组及假手术组;超微高剂量组作用优于传统汤剂组。
(4)超微补阳还五汤可上调脑缺血后脑组织NGF及其受体TRKA的表达,并增强PI3K/AKT信号转导的表达,其作用明显优于模型组及假手术组;超微高剂量组与传统汤剂比较其影响有明显增高的优势。
结论:
(1)补阳还五汤及其超微制剂可以改善局灶性脑缺血大鼠神经功能缺损评分及脑组织病理变化,提高脑缺血后血液SOD活性并降低MDA活性以减弱氧自由基的毒性反应,对脑缺血神经元损伤具有保护作用。
(2)超微补阳还五汤保持了传统补阳还五汤中的有效成分,且有效成分的溶出相对传统汤剂更具优势。
(3)超微补阳还五汤可提高脑缺血后脑组织神经营养因子PI3K/PKB信号转导途径的表达,提高神经生长因子及其受体表达水平,这可能是超微补阳还五汤对脑缺血神经元损伤的保护作用机制之一。
(4)超微补阳还五汤以1/2等效剂量时即可达与传统汤剂相同的作用效果,以等效剂量时其作用效应有明显增加的趋势。
综上,本论文采用药物化学、药理学方法以及免疫组化、分子生物学方法,以超微技术对补阳还五汤复方制剂与传统补阳还五汤标准汤剂进行对照研究,论证了超微技术在促进中药复方制剂(补阳还五汤)有效成分溶出上的优势,并从神经营养因子通路(即信号转导机制)角度揭示了超微补阳还五汤的作用机制,具有显著的创新性。
Foreword: Ischemia stroke is a frequent and common disease with high mortality and high disability in clinical work. The study show that neuronal injury following cerebral ischemia is the main part of pathological mechanism's study. So the searching of drugs for protect cerebral ischemia neuronal injury is a hotspot in this domain. BuYangHuanWu is one of the medicament with positive curative effect and obvious trait for Ischemia stroke.
Objective:
(1) Investigate the trait of the ChaoWei-BuYangHuanWu by contrasting the main effective element in ChaoWei-BuYangHuanWu and BuYangHuanWu, make some rewarding work for the medicament reform of Chinese traditional medicine.
(2) Study the effection of protecting the neuronal injury following cerebral ischemia , and make sure the mechanism by the experimentation in MCAO rat. Offering some experience for the clinical work on Ischemia stroke.
Methods:
(1) Make sure the effective element of ChaoWei-BuYangHuanWu by series test: Study the essential element of Chinese angelica Root, Red Peony Bark, Chuangxiong Rhizome, Safflower and Peach Kernal by TLC; and measure the content of the main useful element in ChaoWei-BuYangHuanWu; Make sure the content of specifically metal , complex and water-solubility- lixivium \alc-ohol-solubility-lixivium by the ways which was recorded by PharMCAOpoeia Of People's Republic Of China.
(2)Make MCAO rats by special ways, divide the rats to 6 group; and abserve the rats at 1\ 4\ 7 and 14 days, observe and record the given symptoms, give the grade by the symptoms; after the test, kill the rats and take blood , then detect the actives of SOD and MDA in blood by given ways ; after all, take the brain , Immunohistochemical avidin-biotin peroxidase complex method was applied to detect the expression of NGF and his Receptor TRKA; And In Situ Hybridization with Nick-Translated Probes was applied to detect the PI3K/PKB, which was the main Intracellular signal transduction of NGF.
RESULTS:
(1) showing the same color spot in the corresponding place on the chromato-gram of each sample of the two groups measured by TLC, and the spot is more distinctive in the effective element of ChaoWei-BuYangHuanWu.It is showed that the content of Astragaloside IV in ChaoWei-BuYangHuanWu is equivalent in the traditional decoction, the content of arsenide and specifically metal is not in superscale. It is found that the water-solubility- lixivium is 1.22 times and the alcohol-solubility-lixivium is 1.26 times in ChaoWei-BuYangHuanWu than in the traditional decoction.
(2) ChaoWei-BuYangHuanWu can reduce the grade of the the neuronal injury following cerebral ischemia, improve the pathological injury of cerebral ischemia. It is statistically different than the model group and artificial operation group, the effection of high dosage ChaoWei-BuYangHuanWu is statisti- cally better than traditional decoction.
(3 ) ChaoWei-BuYangHuanWu can improve the active function of SOD, reduce the active function of MDA. This function is statistically different than the model group and artificial operation group, the effection of high dosage ChaoWei-BuYangHuanWu is statistically better than traditional decoction.
(4) ChaoWei-BuYangHuanWu can raise the expression of NGF and his Receptor TRKA after cerebral ischemia, and boost up the signal transduction of PI3K/AKT.This function is statistically different than the model group and artificial operation group, the effection of high dosage ChaoWei-BuYangHuan Wu is statistically better than traditional decoction.
CONCLUSION:
(1) BuYangHuanWu decoction and it's ChaoWei-preparation can improve the neuronal function grades and pathological changes of rats with partial cerebral ischemia;It can improve the active function of SOD, reduce the active function of MDA to weaken the toxic of superoxide free radicals. It is protective to the injuried neurocyte of cerebral ischemia.
(2) ChaoWei-BuYangHuanWu kept the effctive element, as well as the traditional decoction and it is better than the traditional decoction in solubility -lixivium.
(3) ChaoWei-BuYangHuanWu can boost up the signal transduction of PI3K/ PKB that is a kind of Neurotrophic factor. It also can raise the expression of NGF and his Receptor TRKA after cerebral ischemia. This is likely to be one of the protective mechanism of ChaoWei-BuYangHuanWu to neuronal injury following cerebral ischemia.
(4) 1/2 equivalent effective dosage of ChaoWei-BuYangHuanWu can make the same effecion of the traditional decoction. It is prone to be effective stronger when used the equivalent effective dosage.
Above all, this topic adopted Pharmaceutical method, method of pharMCAOlogy, Immunohistochemical method and molecular organism, demonstrated the asc- endancy of promoting solubility-lixivium of effective element in traditional Chinese medicine (BuYangHuanWu decoction) by contrasting ChaoWei-BuY- angHuanWu in which ultramicro technology was used and traditional BuYang- HuanWu decoction, and revealed the mechanism of action in the view of signal transduction of Neurotrophic factor. So this topic had great new ideas.
引文
1.常富业,王永炎.中风病发病学研究述评[J].辽宁中医杂志,2004,31(2):102-103.
2.赵国强.缺血性中风药物治疗现状[J].医学综述,1999,(4):153-155.
3.李菁.缺血性脑血管病神经保护治疗的研究进展[J].药物临床治疗杂志,2005,3(6):16-20.
4.马爱军,张金钟,张本恕.脑梗塞的神经保护治疗[J].医学与哲学,2006,27(2):36-37
5.刘新峰,脑血管病神经保护治疗的现状!趋势及存在问题[J].医学研究生学报,2003,16(6):452-455.
6.王志均,朱文玉.细胞保护[M].北京:北京医科大学,中国协和医科大学联合出版社,1995.437-455.
7.张晓文,宋清,徐志伟.内源性保护对中医药研究的启发和意义[J].上海中医药杂志,2006,40(1):14-16.
8.周健,孙克华.神经损伤后的再生与神经营养因子[J].中国微侵袭神经外科杂志,2006,11(1)36-38.
9.张学文.《医林改错》一书的学习与活血化瘀方药的运用[J].天津中医药,2006年23(1):1-5.
10.范京国,同东民.补阳还五汤临床应用研究进展[J].甘肃中医.2002,15(2):81-82.
11.王敏,邓常青.补阳还五汤抗脑缺血作用的研究概况与展望[J].湖南中医学院学报.2000,20(4):71-72.
12.沈平镶,何筑生.微药粉体工程技术与中药现代化[J].世界科学技术,1999,1(3):26-29.
13.张亚红,刘红宁,朱卫丰.超微粉碎技术及其在中药制药中的应用[J].江西中医学院学报.2002,14(1):57-58.
14.俞月萍,徐秋琴,魏尔清.急性缺血性卒中的神经保护药物研究进展[J].中国临床药理学与治疗学[J],2005,10(8):841-845.
15.武力卿.缺血性中风的药物治疗[J].药学进展,2003,(5):303-306.
16.周鸿雁,毛海峰,王一蓉,刘仁义.脑缺血损伤的研究进展[J].湖南文理学院学报(自然科学版),2005,(2).72-75.
17.余冬子,范华燕,余绍祖.神经保护剂治疗缺血性脑血管病研究进展.郧阳医学院学报,1999,18(2),121-124.
18.李惠.缺血性脑血管疾病[M].北京:北京科学技术出版社,2002:47-57.
19.Liu XF.Current status of neuroprotection in cerebrovascular disease[J].Journal of Medical Postgraduates,2003,16(6):452-455.
20.蒋晓江,李书林.缺血缺氧性脑病的神经保护[J].中国临床康复,2004,28(8):6163-6166.
21.VILLRINGER A,DIRNAGL U.Pathophysiology of cerebra lischemia[J].Arztl Fortblild Aualitatssich,1999,93:164-168.
22.黎红华,郑彩梅.实验性脑缺血在体及体外兴奋性氨基酸的改变及其意义[J].卒中与神经疾病,1996,3(4):182-1843.
23.Zivin JA,Choi DW.Scientific American,1991,265:36-43.
24.杨惠玲主编.高级病理生理学[M].北京:科学出版社,1998.24-38.
25.苏静怡.心血管疾病的病理生理基础和发病机制[J].北京医科大学协和医科大学联合出版社,1994.165-165.
26.田恒力,张镛.一氧化氮生物作用的研究进展[J].国外医学.神经病学神经外科学分册,1995,22(2):87-90.
27.IADECOLA C.Bright and dark sides of nitric oxide in ischemic brain injury[J].Trends Neurosci,1997,20:132-139.
28.Dawson VL,Dawson TM,Bartley DA.et al.Mechanisms of Nitric oxide-mediated neurotoxicity in primary brain cultures.J Neurosci,1993,13:2651-2661.
29.钟慈声,孙安阳.一氧化氮的生物医学.上海医科大学出版社,1997.199-199.
30.钱海蓉,王鲁宁.缺血性卒中的神经保护剂研究进展[J].中国药物应用与监测,2006,1:30-34.
31.陈道文 编译 李作汉.神经保护剂治疗急性缺血性卒中临床研究近况.国外医学脑血管疾病分册,1998,6(6):349-351.
32.刘艳,罗祖明.脑缺血与内源性神经保护[J].国外医学脑血管疾病分册,2004, 12(8):589-592.
33.张晓文,宋清,徐志伟.内源性保护对中医药研究的启发和意义.上海中医药杂志,2006,40(1):14-17.
34.董伟为,主编.神经保护的基础与临床.北京:科学出版社,2002.
35.苏镇培,卢林.脑缺血时的脑保护.现代实用医学,2002,14.635-637.
36.Wardsa J.Neuroproctective role of adenosine in the CNS.Pol J Pharmaol,2002,54:313-326.
37.Nakamura M,Nakakinura K,Mstsumoto M,etal.Rapid tolerance to focal cerebral ischemia in rots is atte nuated by adenosine Al receptor antagonist.J Cereb Blood Flow Metab.2002,22:161-170.
38.Kitagawa H,Mori A,Shimada J,etal.Intracerebral adenos ineinfusion improves neurological outcome after transient focal ischemia in rats.Neurol Res,2002,24:317-323.
39.Mulir KW,Lees KR.Arandomized,double blind,placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke.Ann N Y Acad Scl,1995,765:315-316.
40.Tuszynki mh.Neurotrophic factor[A].Tuszynski MH,Koedower J.CNAS tegeneration[M].San diego:Academic Press,1999,109-158.
41.Chen ZY,Caol,Wang LM,etal.Devolopment of neurotrothic factor for tretment of nueuodegeneration[J].Curr Protein Pep Sci,2001,2(3):261-276.
42.余云开,华仲慰,李玉书.神经营养素家族[J].国外医学分子生物学分册,1995,17(3):127-130.
43.杨卫红,林敬明.神经营养因子的两类受体:Trks及p75[J].中国神经免疫学和神经病学杂志,2002,9(4):244-246.
44.李杰,蒋电明.神经生长因子与周围神经损伤[J].中国临床康复.2005,9(5):150-151.
45.侯亚莉,华克胜.神经营养因子[J].医学综述,2005,11(6):489-491.
46.Rocha M,Martins RA,Linden R.Activation of NMD Areceptors protects against glutamate neurotoxicity in the retina:evidence for the involvement of neuro trophins[J].BrainRes,1999,827(122):79-92.
47.ChengB,Mattson MP.NT-3 and BDNF protect CNS neurous against metabolic excitotoxic insults[J].BrainRes,1994,640(122):56-67.
48.Hee Han B,Dc Costa A,Back SA,etal.BDNF blocks caspase-3 activation in neonatal hypoxia ischemia[J].Neurobiol Dis,2000,7(1):38-53.
49.Sinson G,Perri BR,Troyanowsli JQ,etal.Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death follow ingneurotrophin infusion after experimental traumatic brain njury[J].J Neurosurg,1997,86(3):511-518.
50.Kiprianova I,Feiman TM,Desiderato S,etal.Brain derived neurotrophic factor prevents neuronal death and glial activation after global ischemia in the rat[J].J NeurosciRes,1999,56(1):21-27.
51.Ballarin M,Ernfors P,Lindefore N.Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain[J].Exp Neurol,1991,114(1):35-43.
52.Du J,Feng L,Yang F,et al.Activity and Ca~(2+)dependent modulation of surface expression of brain-derived neurotrophic factor.Receptors in hippocampal neurous[J].J Cell Boil,2000,150(6):1423-1434.
53.李智,任一萍.神经生长因子的信号转导[J].生命的化学,1998,18(4):13-16.
54.王爽,谢鹏,赵裕光,等.PI3K/AKT信号途径在大鼠脑源性神经干细胞中的作用.江西医学院学报.2005,45(5):1-4.
55.徐巳奕,包映晖,江基尧.神经营养因子与血脑屏障的研究进展[J].中华神经医学杂志,2005,(1).92-92.
56.陈可冀.脑血管病的治疗[J].中西医结合杂志,1990,10(6):327-329.
57.蔡光先,杨永华,李跃辉.超微粉体技术与中药饮片改革[J].世界科学技术-中医药现代化,2004,(2).67-70.
58.郑虎占,董泽宏,佘靖.中药现代研究与应用(第三卷),第1版,北京:学苑出版社,1998.
59.北京医学院.中草药成分化学,第1版,北京:人民卫生出版社,1980.
60.国家药典委员会.中国药典(2005年版),一部,北京:化学工业出版社,2005.
61.Longa EZ,Weinstein PR,Carson S,etal.Reversible middle cerbral artery:occlusion without cranietomy in rats.Stroke,1989,20:84-88.
62.Koizumi J,Yoshid Y,Nakazawa T,etal.Experimental studies of ischemia brina edema:A new experimental model of cerebral embolism in rats in which recirulation can be introduced in the ischemia area.Stroke,1986,8:1-5.
63.孙敬方.《动物实验方法学》.人民卫生出版社2001,11,第一版.
64.胡学军,蔡光先,杨永华,郑爱华.中药超微粉碎研究进展与思考[J].世界科学技术,2002,4(5),62-64.
65.Ponten U,Ratcheson RA,Salford LG.Optimal freezing conditions for cerebral metabolites in rats[J].Neurochem,1973,21:1127-1138.
66.王军.大鼠脑缺血模型研究进展[J].中医研究,2002,15(5):60-62.
67.付蔓华,邹明辉,王玉升,等.花生四烯酸诱导大鼠急性脑缺血机理的实验研究[J].中国病理生理学杂志,1991,7:59-61.
68.李威,李秋凤,苗利军,等.通腑化痰活血法对大鼠脑梗塞后血液流变学的影响[J].中药药理与临床,1996,12.31-32.
69.Kulue JW,Prado RJ,Dietrich D.etal.The effect of nitric oxide synthase inhibition on infarct volume after reversible focal ischemia in concions rats[J].Stroke,1993,24:20-23.
70.刘运泉,戴颖.线栓法大鼠局灶性脑缺血模型的改进[J].中国临床解剖学杂志.2005,23(2):222-223.
71.Kuge Y,Minematsu K,Yamaguchi T,etal.Nylon monofilament for intraluminal iddie cerebralartery occlusion in rats[J].Stroke,1995,26(9):1655-1658.
72.Ludmila Belayev,Ofelia F.Alonso,etal.Middle Cerebral Artery Occlusion in the Rat by Intraluminal Suture[J].Stroke,1996,27:16I6-1623.
73.卞杰勇,周代,大鼠局灶性脑缺血再港灌注模型的改进[J],苏州医学院学报,1998,18(3),226-228.
74.Crumrine RC,Thomas AL,Morgan PF.Attenuation of p53 expression protects against focal ischemic damage in transgenic mice[J].J Cereb Blood Flow Metab,1994,14:887-891.
75.Jolly RD,Walkley SU.Ovine ceroid Lipofusion:postulated mechanism of meurodeyneration,Mol Gener[J].Metab,1999,66(4):376-380.
76.Rosenbaum DM,Kalberg J,Kessler JA.Superoxide dismutasea eliorates neuronal death from hypoxia in culture[J].Stroke,1994,25(4):857-862.
77.于肇英.神经生中因子的研究.生理学进展,1998,19(4)226-228.
78.王良斌,吴馥梅.神经生长因子对小鼠海马突触体内Ca~(2+)的影响[J].上海第二医科大学学报,2000,(1).9-11.
79.金大成,王铁民,方秀斌.CGRP和NGF对短暂性全脑缺血后再灌注大鼠纹皮质Caspase-3蛋白表达的影响[J].神经解剖学杂志,2004,(3):296-300.
80.罗学港.神经营养因子的信号转导途径[J].国外医学·生理、病理科学与临床分册,2002,22(4):315-319.
81.Dudek H,Dana SR,Frabke TF,et al.Regulation kinase Akt of neuronal survival by the serine-threonine protein[J].Science,1997,275(5300):661-665.
82.韩彩萍,胡长林.PI3K/AKT信号通路与脑缺血神经细胞凋亡[J].国际神经病学神经外科学杂志,2006,33(1):88-92.
83.Mazzoni IE,Said FA,Aloyz R,etal.Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway[J].J Neurrosci,1999,19:9716-9727.
84.Aschroft M,Stephens RM,Hallberg B,etal.The selective and inducible activation of endogenous PI3-kinase in PC12 cells results in efficient NGF-mediated survival but defective neurite outgrowth[J].Oncogene,1999,18:4586-4597.
1.夏永良.王清任活血化瘀方剂用药规律探讨[J].中医药学刊,2006,(1).95-96.
2.杨鑫.中西医结合治疗急性脑梗死94例疗效观察[J].实用中西医结合临床,2006,(1).34-34.
3.贾满仓,朱薇.补阳还五汤治疗脑梗死90例[J].河南中医,2006,(2).78-79.
4.蔡华,邵卫,何太文.加味补阳还五汤治疗椎-基底动脉缺血性眩晕疗效观察[J].吉林中医药,2006,(3).691-697.
5.屈直,韩新建.补阳还五汤治疗中风后遗症36例临床观察[J].医药产业资讯,2006,(6).75-75.
6.任保顺.天麻钩藤饮合补阳还五汤治疗脑梗死体会[J].中国社区医师(综合版),2006,(4).700-702.
7.朱应文,陈书忠.补阳还五汤治疗中风后遗症期病人的血液流变学观察(附150例报告)[J].哈尔滨医药,2005,(6).98-102.
8.韩峭立.中西医结合治疗缺血性脑血管病32例临床分析[J].实用中西医结合临床,2005,(6).37-37.
9.贾永忠.补阳还五汤加味治疗脑梗死疗效观察[J].山西中医,2005,(6).23-36.
10.罗卫东,李力.补阳还五汤治疗中风后遗症150例疗效观察[J].中医药学报,2005,(5).49-49.
11.柯锋,吴洪,邓春龄,吴民献,蔡柏,万诚,曾坤全,方林彬.补阳还五汤对气虚血瘀型和非气虚血瘀型缺血性中风病人的疗效比较[J].中西医结合心脑血管病杂志,2005,(11).962-963.
12.吴基良,刘超.补阳还五汤对大鼠局灶性脑缺血再灌注损伤的保护作用[J].中国老年学杂志,2004,(6).551-553.
13.文志斌,尚改萍,何晓凡,熊石龙,汉建忠,刘发益,周春生,肖振军,李俊成,贺石林.补阳还五汤对凝血酶诱导血管内皮细胞释放NO,vWF,TFPI及表达组织因子的影响[J].湖南医科大学学报,2002,(4).551-553.
14.尚改萍,文志斌,李俊成,汉建忠,熊石龙,贺石林,肖振军,周春生.补阳还五汤对TNF-a诱导血管内皮细胞释放vWF及表达组织因子的影响[J].湖南医科大 学学报,2000,(2).129-131.
15.陈利国,屈援,葛红颖,胡小勤,聂优爱,何孟栖.补阳还五汤对血瘀证大鼠血管内皮细胞黏附分子表达的影响[J].中草药,2005,36(5).706-709.
16.谭锋.欧正武.补阳还五汤的钙拮抗作用对脑水肿细胞超微结构变化的影响[J].深圳中西医结合杂志,1997,7(2):25-26.
17.张运克.补阳还五汤拆方对脑缺血再灌注SD大鼠模型脑组织含水量及Ca2+含量的影响[J].中医药学刊,2003,21(11):1829-1830.
18.郭彦坤.补阳还五汤对局灶性脑缺血的保护作用,黑龙江中医药,2006,1,19
19.莫孙炼,郑有顺.补阳还五汤拆方对实验性脑缺血损伤大鼠脑组织皮层梗塞面积及血浆内皮素的影响[J].中药药理与临床,1997,23(1).56-59.
20.吴玉生,姜立萍.补阳还五汤对早期脑梗塞患者内皮素、降钙素基因相关肽的影响[J].中药药理与临床,1998,15(2).4-7.
21.张运克.补阳还五汤及拆方对脑缺血再灌注模型大鼠血清及脑组织超氧化物歧化酶及丙二醛和一氧化氮含量的影响(英文)[J].中国临床康复,2005,(9).366-369.
22.蔡冬梅,殷胜利,吴伟康.补阳还五汤治疗气虚血瘀型冠心病的临床疗效及血浆中NO含量的改变[J].现代医学,2004,40(1).25-28.
23.陈秀芳,张玲,李丽仕.补阳还五汤提取物对脑缺血再灌流后一氧化氮合酶活性的影响[J].卒中与神经疾病,2001,9(2).288-289.
24.张红宇,高菊珍,张晓华.补阳还五汤对气虚血瘀证大鼠血液流变学的影响[J].云南中医学院学报,2000,(3).10.
25.赵玉霞,楚中华,孔令钧.补阳还五汤对中风患者血小板及纤溶活性的影响[J],山东中医杂志,2001,20(5),336.
26.张继平,张玉萍,文凤妮,等.补阳还五汤对大鼠静脉血栓形成前后静脉血中血小板活化因子含量的影响[j],中国实验方剂学杂志,1998,4(5),18.
27.高兆录,司毅,贺景宏,补阳还五汤合用维生素(对急性脑梗死患者自由基及血液流变性的影响[j],中国中西医结合急救杂志,2000,7(1):57.
28.刘志龙,邓常青,葛金文,等.补阳还五汤对兔脑缺血再灌注损伤)TXA2/PGI2、环核苷酸及钙的影响[j],中医药理与临床,1996,12(4):5.
29.毛小平,谢忠明.补阳还五汤提取物对家兔高胆固醇血症和血液流变性影响的实验研究[J],微循环学杂志,2001,11(4):19.
30.高颖,蔡定芳.大脑中动脉阻塞大鼠MMP9基因表达及补阳还五汤对其影响保护作用,中成药,2003,25(7):560-562.
31.赖真,王沙燕,耿小茵,张阮章,段晓慧,邓常青.补阳还五汤和黄芪对沙土鼠脑缺血再灌注后脑组织兴奋性氨基酸的影响[J].北京中医药大学学报,2002,(3).
32.Erecinska M,Silver IA.ATP and brain function[J].J Cereb Blood Flo wMetab,1989,9(1):2-19.
33.刘志龙,宋含平,邓常青,等.补阳还五汤对沙鼠脑缺血损伤细胞凋亡的影响及机理研究[J].广州中医药大学学报,2000,17(4):318-319.
34.邓常青,邓奕晖,向华林,贺福元,唐映红.补阳还五汤及其有效部位对沙鼠脑缺血后DND脑能量代谢、NO和NOS的影响[J].中药药理与临床,1999,(5).3.
35.张运克,魏明,宰军华.补阳还五汤及拆方对脑缺血再灌注模型血清、脑组织的SOD、MDA及NO含量影响[J].中药新药与临床药理,2003,14(6):366-359.
36.邢三丽,李振华,孙晋浩,刘岳鹏,暴丽华.补阳还五汤提取液对Schwann细胞氧化损伤的保护作用[J].神经解剖学杂志,2006,(1).95-98.
37.邢三丽,李振华,孙晋浩,刘岳鹏,暴丽华.补阳还五汤的抗氧化作用[J].解剖学杂志,2005,(5).529-531
38.郭平,王浩,王晶.补阳还五汤对实验性脑缺血再灌注损伤抗氧化作用的研究[J].山东中医杂志,2001,20(10).621-623.
39.胥显民,陈显久,补阳还五汤对大鼠全血比粘度、TXB2、LPO和SOD的影响[J],山西医科大学学报,2002,33(3),212-214.
40.Lipton SA,Resenberg PA.Mechanisms of disease:excitatory amino acids as a final common pathway for neurologic disorders[J].N Engl J Med,1994,330:613-625.
41.吴基良,刘超.补阳还五汤对大鼠局灶性脑缺血再灌注损伤的保护作用[J].中国老年学杂志,2004,26(6).10-12.
42.耿小茵,赖真,邓常青,等.补阳还五汤对鼠脑缺血再灌注后脑组织兴奋性氨基酸的作用[J].广州中医药大学学报,2004,21(2):125-127.
43.邓常青,邓奕晖,贺福元等.补阳还五汤和有效部位组方对沙土鼠脑缺血及再灌注后脑组织EAA的影响[J].中国实验方剂学杂志,2001,7(6):24-27.
44.Hangai.M et al.Inducible Nitric Oxide Synthase in Retinal Ischemia-ReperfusionInjury[j].Exp Eye Res,1996,63(5):501-509.
45.郭平,王晶,王浩.补阳还五汤抗脑缺血再灌注损伤作用机理的研究[J].中药药理与临床,2001,17(2).3-4.
46.廖春来,佟丽,陈育尧.补阳还五汤对脑缺血大鼠nNOS免疫阳性神经元的影响[J].第一军医大学学报,2004,24(8):864-366.
47.Mlainskit.Bailey F.Zhang ZG.Et al.Nitric oxide measured by a porphyrinic mic rosensor in rat brain after transient middle cerebral aftery occlusion[J].J Cereb Blood Flow Metab,1993,13:355-390.
48.Sato s.et al.Role of Nitric Oxide in brain ischemia[j],Ann NY Aca Sci,1994,738:369-374.
49.刘志龙,宋含平,邓常青,韩绍娟.补阳还五汤对沙土鼠脑缺血损伤能量代谢的影响[J].中国中西医结合急救杂志,2001,8(1).36-37.
50.Feuerstein GZ,Liu T,Barone FC.Cytokines inflammatin and brain injury:role of tumornecrosi s factora.Cerebrovase Brain Metab Rev,1994,6:3417-3422.
51.Chopp M,li jing N.Antibodis against adhesion molecule reduce apoptosis after transient cerebral middle artery occlusion rat brain.Jcereb Blood Flow Metab,1996,16:578-567.
52.毛小平,唐尊立,段申汉.白细胞浸润及脑梗死体积的影响,卒中与神经疾病,2002,9(5),288-291.
53.韩绍娟,刘志龙.补阳还五汤对沙土鼠脑缺血再灌注损伤后血清炎性细胞因子IL-1β、IL-6、TNF-α的影响[J].实用中西医结合临床,2004,(4).1-3.
54.成细华,邓奕辉,梅志刚,丁志高,喻嵘,田道法.补阳还五汤对缺氧-复氧内皮细胞ICAM-1 mRNA表达影响的研究[J].湖南中医学院学报,2004,(2).4-6.
55.Reynold BA,Weiss S.Generation of neu tons and astrocytes from isolated cells of the adult mammalian central nervous system[J].Science,1992,255(5052):1707-1711.
56.孙晋浩,杨琳,高英茂,李振华,底秀敏.补阳还五汤对神经干细胞生长分化的影响[J].山东大学学报(医学版),2002,40(5).406-408.
57.刘柏炎,蔡光先,林琳,曾序求,丁志高.补阳还五汤对大鼠局灶性脑缺血后神经干细胞影响的初步研究[J].中国临床康复,2004,(22).4532-4533.
58.刘柏炎,蔡光先.补阳还五汤对低糖低氧损伤神经干细胞移行分化的影响[J].中 国药物与临床,2005,5(3).171-173.
59.蔡光先,刘柏炎.补阳还五汤对体外低糖低氧损伤海马神经干细胞增殖的影响[J].湖南中医学院学报,2005,25(2).1-3.
60.吕晓红,许丽艳,李恩民,等.一氧化氮在迟发性神经元坏死中与程序性细胞死亡关系的研究[J],中风与神经疾病杂志,1997,2(1),68-71.
61.钱叶斌,陶有略,黄翠芬,武一曼.补阳还五汤促进周围神经损伤后神经元存活的实验研究.实用手外科杂志.2002,12(3),152-156.
62.刘志龙,宋含平.补阳还五汤对沙土鼠脑缺血损伤细胞凋亡影响及机理的研究[J],广州中医药大学学报,2000,17(4),318-321.
63.邓常青,贺福元.补阳还五汤及其有效部位组方对沙士鼠脑缺血再灌注后海马*A%区超微结构的影响6'8,中药药理与临床,2000,16(3),7-9.
64.彭力宏,李翠屏,郑吉民.补阳还五汤含药血清对体外培养大鼠皮层神经元缺氧凋亡的影响[J],广州中医药大学学报,2002,19(3),207-210.
65.曲宏达.补阳还五汤药物血清对体外培养大鼠皮层神经元缺氧后p53和p21表达的影响,中国中西医结合杂志,2002,24(3),133-135.
66.王新高,童萼塘,孙圣刚.补阳还五汤对脑缺血再灌注大鼠皮质神经细胞凋亡的影响[J].中国比较医学杂志,2005,15(6),363-367.
67.彭康,孙忠.补阳还五汤对中风后遗症“气虚血瘀”大鼠脑组织三磷酸腺苷及二磷酸腺苷和单胺类神经递质的影响,中医康复研究,2004,8(10),1908-1911.
68.韩东,廖福龙,李文,等.补阳还五汤及拆方对血栓形成大鼠梗塞灶、血管损伤平暗区、血浆t-PA,PAI活性及ET含量的影响[J]中国实验方剂学杂志,2001,7(2):21-24.
69.林桂涛,尹宁宁,马承严,等.应用均匀设计筛选补阳还五汤处方[J].中药材,1997,7(7):364-365.
70.姚晖,吴勇杰,张继平,陈芝喜,李志强,陈津岩,何赞厚.补阳还五汤体外对家兔血小板PAF受体活性影响的拆方研究[J].新中医,2005,(12).82-84.
71.张振强,张运克.补阳还五汤对脑缺血再灌注大鼠血浆TXB_2、6-keto-PGF_1a含量的影响[J].河南大学学报(医学科学版),2004,(3).9-11.
72.张运克,魏明,宰军华.补阳还五汤及拆方对脑缺血再灌注模型血清、脑组织的SOD、MDA及NO含量影响[J].中药新药与临床药理,2003,14(6):366-369.
1.Tuszynki mh.Neurotrophic factor[A].Tuszynski MH,Koedower J.CNAS tegeneration [M].San diego:Academic Press,1999,109-158.
2.Chen ZY,Caol,Wang LM,etal.Devolopment of neurotrothic factor for tretment of nueuodegeneration[J].Curr Protein Pep Sci,2001,2(3):261-276.
3.KrekoskI BV.Isolation and characterization of nerve growth factor(NGF) excreted from caltured eukaryotic cells.J Nat Toxims.2001:10(3):213-219.
4.Hantzopoulos PA,Suri C,Glass DJ,et al.The low affinity,NGF receptor,P75,can collaborate with each of the Trks to potentiate functional responses to the neurotrophins.Neuron.1994:13(1):187-201.
5.Roux PP,Barker PA.Neurotrophin signaling through the p75 neu-rotrophin receptor.Prog Neurobiol,2002,67:203-233.
6.Walton M,Connor B,Lawlor P,et al.Neuronal death and survival in two models of hypoxic-ischemic brain damage.Brain Res Brain Res Rev,1999,29:137-168.
7.Ballarin M,Ernfors P,Lindefore N.Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain[J].Exp Neurol,1991,114(1):35-43.
8.8.Du J,Feng L,Yang F,et al.Activity and Ca2+ dependent modulation of surface expression of brain-derived neurotrophic factor.Receptors in hippocampal neurous[J].J Cell Boil,2000,150(6):1423-1434.
9.Kenneth P,Madden MD.Effect of gamma r-aminobutyric acid modulation on neuronal ischemia in rabbits.Stroke,1994,25(11):2271-2275.
10.王良斌,吴馥梅.神经生长因子对小鼠海马突触体内[Ca2+]的影响[J].上海第二医科大学学报,2000,20(1),9-11.
11.张建国,张颖,王忠诚,栾国明,宋咏梅,王丽.代谢性损害对培养的海马神经元形态结构和Ca2+含量的影响[J].中华神经外科杂志,1999,15(6):368-370.
12.林凌,张鹤云,顾海明,汤国枝,张祖暄,张维宁,陈荣三.神经生长因子在培养的皮质神经细胞中抑制谷氨酸毒性[J].中国药理学报,1996,(3).
13.Cheng B,Mattson MP.NT-3 and BDNF protect CNS neurous against metabolic excitotoxic insults[J].Brain Res,1994,640(122):56-67.
14.Rocha M,Martins RA,Linden R.Activation of NMDA receptors protects against glutamate neurotoxicity in the retina:evidence for the involvement of neurotrophins [J].BrainRes,1999,827(122):79-92.
15.吴俊芳,张均田.神经生长因子对谷氨酸及过氧化氢介导的新生大鼠脑细胞内游离钙浓度升高的影响(英)[J].Journal of Chinese Pharmaceutical Sciences,1999,(1).
16.Faleiro L,Kobayashi R,Fearnhead H etal.Multiple species of CPP-32 and Mch2 are the major active caspase present in apoptotic cells.EMBOJ,1997,16:2271-2281.
17.金大成,王铁民,方秀斌.CGRP和NGF对短暂性全脑缺血后再灌注大鼠纹皮质Caspase-3蛋白表达的影响[J].神经解剖学杂志,2004,(3).254-260.
18.Enari M,Sakahira H,Yokoyama H et al.Acaspase-activated D Nase that degrades DNA during apoptosis,and its inhibitor ICAD.Nature,1998;391:43-50.
19.秦建兵,毛伟峰,金国华,田美玲,张毅,徐慧君.大鼠创伤性脑损伤后神经元的凋亡及NOS、NGF-R、bcl-2、ChAT阳性神经元的变化[J].交通医学,2003,(5).30-33.
20.Hee Han B,Dc CostaA,Back SA,et al.BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia[J].Neurobiol Dis,2000,7(1):38-53.
21.Sinson G,Perri BR,Troyanowsli JQ,et al.Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death following neurotrophin infusion after experimental traumatic brain injury[J].J Neurosurg,1997,86(3):511-518.
22.KiprianovaI,Feiman TM,Desiderato S,et al.Brain-derived neurotrophie factor prevents neuronal death and glial activation after global ischemia in the rat[J].J Neurosei Res,1999,56(1):21-27.
23.徐正冬,李贯菲.BDNF,NGF在大鼠局灶性脑缺血的表达变化及葛根素对其影响的实验研究.中国实验诊断学.2005,9(4),578-580.
24.王佩,齐浩波,乔占涛,王淑敏.李育臣局灶脑缺血大鼠脑源性神经营养因子及其受体的表达.中西医结合心脑血管病学杂志.2003,1(3),138-140.
25.钟相根,李澎涛,王永炎.清开灵有效组分对缺血脑组织神经营养因子含量的影响.北京中医药大学学报.2004,27(3),21-25.
26.徐正冬,李贯菲.BDNF,NGF在大鼠局灶性脑缺血的表达变化及葛根素对其影响的实验研究.中国实验诊断学.2005,9(4),578-580.
27.李育臣,董玉娟,王建茹,王冰.银杏叶提取物对脑缺血大鼠脑源性神经营养因子的影响.中风与神经疾病杂志.2005,22(1),55-57.
28.刘昌云,车春晖,黄华品.银杏内酯对大鼠局灶脑缺血再灌注后皮质脑源性神经营养因子(BDNF)表达的影响.海峡药学.2005,17(6),51-55.
29.卢宏,王建平,李昕,张苏明,方思羽.雌二醇对大鼠脑缺血/再灌注损伤脑组织BDNF表达的影响.郑州大学学报(医学版).2005,40,1,47-49.
30.王占军,陆兵勋,姬仲.氟西汀预处理对大鼠脑缺血再灌注海马区BDNF和bcl-2表达的影响.中国微侵袭神经外科医学杂志.2005,10(9),414-416.
31.刘昌云,陈龙飞,许国英,等.亚低温对局灶性脑缺血再灌注大鼠脑皮质脑源性神经营养因子表达及神经元凋亡的影响.中国现代神经疾病杂志.2005,5(6),338-341.
32.徐巳奕,包映晖,江基尧.神经营养因子与血脑屏障的研究进展[J].中华神经医学杂志,2005,(1).92-94.
2.赵国强.缺血性中风药物治疗现状[J].医学综述,1999,(4):153-155.
3.李菁.缺血性脑血管病神经保护治疗的研究进展[J].药物临床治疗杂志,2005,3(6):16-20.
4.马爱军,张金钟,张本恕.脑梗塞的神经保护治疗[J].医学与哲学,2006,27(2):36-37
5.刘新峰,脑血管病神经保护治疗的现状!趋势及存在问题[J].医学研究生学报,2003,16(6):452-455.
6.王志均,朱文玉.细胞保护[M].北京:北京医科大学,中国协和医科大学联合出版社,1995.437-455.
7.张晓文,宋清,徐志伟.内源性保护对中医药研究的启发和意义[J].上海中医药杂志,2006,40(1):14-16.
8.周健,孙克华.神经损伤后的再生与神经营养因子[J].中国微侵袭神经外科杂志,2006,11(1)36-38.
9.张学文.《医林改错》一书的学习与活血化瘀方药的运用[J].天津中医药,2006年23(1):1-5.
10.范京国,同东民.补阳还五汤临床应用研究进展[J].甘肃中医.2002,15(2):81-82.
11.王敏,邓常青.补阳还五汤抗脑缺血作用的研究概况与展望[J].湖南中医学院学报.2000,20(4):71-72.
12.沈平镶,何筑生.微药粉体工程技术与中药现代化[J].世界科学技术,1999,1(3):26-29.
13.张亚红,刘红宁,朱卫丰.超微粉碎技术及其在中药制药中的应用[J].江西中医学院学报.2002,14(1):57-58.
14.俞月萍,徐秋琴,魏尔清.急性缺血性卒中的神经保护药物研究进展[J].中国临床药理学与治疗学[J],2005,10(8):841-845.
15.武力卿.缺血性中风的药物治疗[J].药学进展,2003,(5):303-306.
16.周鸿雁,毛海峰,王一蓉,刘仁义.脑缺血损伤的研究进展[J].湖南文理学院学报(自然科学版),2005,(2).72-75.
17.余冬子,范华燕,余绍祖.神经保护剂治疗缺血性脑血管病研究进展.郧阳医学院学报,1999,18(2),121-124.
18.李惠.缺血性脑血管疾病[M].北京:北京科学技术出版社,2002:47-57.
19.Liu XF.Current status of neuroprotection in cerebrovascular disease[J].Journal of Medical Postgraduates,2003,16(6):452-455.
20.蒋晓江,李书林.缺血缺氧性脑病的神经保护[J].中国临床康复,2004,28(8):6163-6166.
21.VILLRINGER A,DIRNAGL U.Pathophysiology of cerebra lischemia[J].Arztl Fortblild Aualitatssich,1999,93:164-168.
22.黎红华,郑彩梅.实验性脑缺血在体及体外兴奋性氨基酸的改变及其意义[J].卒中与神经疾病,1996,3(4):182-1843.
23.Zivin JA,Choi DW.Scientific American,1991,265:36-43.
24.杨惠玲主编.高级病理生理学[M].北京:科学出版社,1998.24-38.
25.苏静怡.心血管疾病的病理生理基础和发病机制[J].北京医科大学协和医科大学联合出版社,1994.165-165.
26.田恒力,张镛.一氧化氮生物作用的研究进展[J].国外医学.神经病学神经外科学分册,1995,22(2):87-90.
27.IADECOLA C.Bright and dark sides of nitric oxide in ischemic brain injury[J].Trends Neurosci,1997,20:132-139.
28.Dawson VL,Dawson TM,Bartley DA.et al.Mechanisms of Nitric oxide-mediated neurotoxicity in primary brain cultures.J Neurosci,1993,13:2651-2661.
29.钟慈声,孙安阳.一氧化氮的生物医学.上海医科大学出版社,1997.199-199.
30.钱海蓉,王鲁宁.缺血性卒中的神经保护剂研究进展[J].中国药物应用与监测,2006,1:30-34.
31.陈道文 编译 李作汉.神经保护剂治疗急性缺血性卒中临床研究近况.国外医学脑血管疾病分册,1998,6(6):349-351.
32.刘艳,罗祖明.脑缺血与内源性神经保护[J].国外医学脑血管疾病分册,2004, 12(8):589-592.
33.张晓文,宋清,徐志伟.内源性保护对中医药研究的启发和意义.上海中医药杂志,2006,40(1):14-17.
34.董伟为,主编.神经保护的基础与临床.北京:科学出版社,2002.
35.苏镇培,卢林.脑缺血时的脑保护.现代实用医学,2002,14.635-637.
36.Wardsa J.Neuroproctective role of adenosine in the CNS.Pol J Pharmaol,2002,54:313-326.
37.Nakamura M,Nakakinura K,Mstsumoto M,etal.Rapid tolerance to focal cerebral ischemia in rots is atte nuated by adenosine Al receptor antagonist.J Cereb Blood Flow Metab.2002,22:161-170.
38.Kitagawa H,Mori A,Shimada J,etal.Intracerebral adenos ineinfusion improves neurological outcome after transient focal ischemia in rats.Neurol Res,2002,24:317-323.
39.Mulir KW,Lees KR.Arandomized,double blind,placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke.Ann N Y Acad Scl,1995,765:315-316.
40.Tuszynki mh.Neurotrophic factor[A].Tuszynski MH,Koedower J.CNAS tegeneration[M].San diego:Academic Press,1999,109-158.
41.Chen ZY,Caol,Wang LM,etal.Devolopment of neurotrothic factor for tretment of nueuodegeneration[J].Curr Protein Pep Sci,2001,2(3):261-276.
42.余云开,华仲慰,李玉书.神经营养素家族[J].国外医学分子生物学分册,1995,17(3):127-130.
43.杨卫红,林敬明.神经营养因子的两类受体:Trks及p75[J].中国神经免疫学和神经病学杂志,2002,9(4):244-246.
44.李杰,蒋电明.神经生长因子与周围神经损伤[J].中国临床康复.2005,9(5):150-151.
45.侯亚莉,华克胜.神经营养因子[J].医学综述,2005,11(6):489-491.
46.Rocha M,Martins RA,Linden R.Activation of NMD Areceptors protects against glutamate neurotoxicity in the retina:evidence for the involvement of neuro trophins[J].BrainRes,1999,827(122):79-92.
47.ChengB,Mattson MP.NT-3 and BDNF protect CNS neurous against metabolic excitotoxic insults[J].BrainRes,1994,640(122):56-67.
48.Hee Han B,Dc Costa A,Back SA,etal.BDNF blocks caspase-3 activation in neonatal hypoxia ischemia[J].Neurobiol Dis,2000,7(1):38-53.
49.Sinson G,Perri BR,Troyanowsli JQ,etal.Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death follow ingneurotrophin infusion after experimental traumatic brain njury[J].J Neurosurg,1997,86(3):511-518.
50.Kiprianova I,Feiman TM,Desiderato S,etal.Brain derived neurotrophic factor prevents neuronal death and glial activation after global ischemia in the rat[J].J NeurosciRes,1999,56(1):21-27.
51.Ballarin M,Ernfors P,Lindefore N.Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain[J].Exp Neurol,1991,114(1):35-43.
52.Du J,Feng L,Yang F,et al.Activity and Ca~(2+)dependent modulation of surface expression of brain-derived neurotrophic factor.Receptors in hippocampal neurous[J].J Cell Boil,2000,150(6):1423-1434.
53.李智,任一萍.神经生长因子的信号转导[J].生命的化学,1998,18(4):13-16.
54.王爽,谢鹏,赵裕光,等.PI3K/AKT信号途径在大鼠脑源性神经干细胞中的作用.江西医学院学报.2005,45(5):1-4.
55.徐巳奕,包映晖,江基尧.神经营养因子与血脑屏障的研究进展[J].中华神经医学杂志,2005,(1).92-92.
56.陈可冀.脑血管病的治疗[J].中西医结合杂志,1990,10(6):327-329.
57.蔡光先,杨永华,李跃辉.超微粉体技术与中药饮片改革[J].世界科学技术-中医药现代化,2004,(2).67-70.
58.郑虎占,董泽宏,佘靖.中药现代研究与应用(第三卷),第1版,北京:学苑出版社,1998.
59.北京医学院.中草药成分化学,第1版,北京:人民卫生出版社,1980.
60.国家药典委员会.中国药典(2005年版),一部,北京:化学工业出版社,2005.
61.Longa EZ,Weinstein PR,Carson S,etal.Reversible middle cerbral artery:occlusion without cranietomy in rats.Stroke,1989,20:84-88.
62.Koizumi J,Yoshid Y,Nakazawa T,etal.Experimental studies of ischemia brina edema:A new experimental model of cerebral embolism in rats in which recirulation can be introduced in the ischemia area.Stroke,1986,8:1-5.
63.孙敬方.《动物实验方法学》.人民卫生出版社2001,11,第一版.
64.胡学军,蔡光先,杨永华,郑爱华.中药超微粉碎研究进展与思考[J].世界科学技术,2002,4(5),62-64.
65.Ponten U,Ratcheson RA,Salford LG.Optimal freezing conditions for cerebral metabolites in rats[J].Neurochem,1973,21:1127-1138.
66.王军.大鼠脑缺血模型研究进展[J].中医研究,2002,15(5):60-62.
67.付蔓华,邹明辉,王玉升,等.花生四烯酸诱导大鼠急性脑缺血机理的实验研究[J].中国病理生理学杂志,1991,7:59-61.
68.李威,李秋凤,苗利军,等.通腑化痰活血法对大鼠脑梗塞后血液流变学的影响[J].中药药理与临床,1996,12.31-32.
69.Kulue JW,Prado RJ,Dietrich D.etal.The effect of nitric oxide synthase inhibition on infarct volume after reversible focal ischemia in concions rats[J].Stroke,1993,24:20-23.
70.刘运泉,戴颖.线栓法大鼠局灶性脑缺血模型的改进[J].中国临床解剖学杂志.2005,23(2):222-223.
71.Kuge Y,Minematsu K,Yamaguchi T,etal.Nylon monofilament for intraluminal iddie cerebralartery occlusion in rats[J].Stroke,1995,26(9):1655-1658.
72.Ludmila Belayev,Ofelia F.Alonso,etal.Middle Cerebral Artery Occlusion in the Rat by Intraluminal Suture[J].Stroke,1996,27:16I6-1623.
73.卞杰勇,周代,大鼠局灶性脑缺血再港灌注模型的改进[J],苏州医学院学报,1998,18(3),226-228.
74.Crumrine RC,Thomas AL,Morgan PF.Attenuation of p53 expression protects against focal ischemic damage in transgenic mice[J].J Cereb Blood Flow Metab,1994,14:887-891.
75.Jolly RD,Walkley SU.Ovine ceroid Lipofusion:postulated mechanism of meurodeyneration,Mol Gener[J].Metab,1999,66(4):376-380.
76.Rosenbaum DM,Kalberg J,Kessler JA.Superoxide dismutasea eliorates neuronal death from hypoxia in culture[J].Stroke,1994,25(4):857-862.
77.于肇英.神经生中因子的研究.生理学进展,1998,19(4)226-228.
78.王良斌,吴馥梅.神经生长因子对小鼠海马突触体内Ca~(2+)的影响[J].上海第二医科大学学报,2000,(1).9-11.
79.金大成,王铁民,方秀斌.CGRP和NGF对短暂性全脑缺血后再灌注大鼠纹皮质Caspase-3蛋白表达的影响[J].神经解剖学杂志,2004,(3):296-300.
80.罗学港.神经营养因子的信号转导途径[J].国外医学·生理、病理科学与临床分册,2002,22(4):315-319.
81.Dudek H,Dana SR,Frabke TF,et al.Regulation kinase Akt of neuronal survival by the serine-threonine protein[J].Science,1997,275(5300):661-665.
82.韩彩萍,胡长林.PI3K/AKT信号通路与脑缺血神经细胞凋亡[J].国际神经病学神经外科学杂志,2006,33(1):88-92.
83.Mazzoni IE,Said FA,Aloyz R,etal.Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway[J].J Neurrosci,1999,19:9716-9727.
84.Aschroft M,Stephens RM,Hallberg B,etal.The selective and inducible activation of endogenous PI3-kinase in PC12 cells results in efficient NGF-mediated survival but defective neurite outgrowth[J].Oncogene,1999,18:4586-4597.
1.夏永良.王清任活血化瘀方剂用药规律探讨[J].中医药学刊,2006,(1).95-96.
2.杨鑫.中西医结合治疗急性脑梗死94例疗效观察[J].实用中西医结合临床,2006,(1).34-34.
3.贾满仓,朱薇.补阳还五汤治疗脑梗死90例[J].河南中医,2006,(2).78-79.
4.蔡华,邵卫,何太文.加味补阳还五汤治疗椎-基底动脉缺血性眩晕疗效观察[J].吉林中医药,2006,(3).691-697.
5.屈直,韩新建.补阳还五汤治疗中风后遗症36例临床观察[J].医药产业资讯,2006,(6).75-75.
6.任保顺.天麻钩藤饮合补阳还五汤治疗脑梗死体会[J].中国社区医师(综合版),2006,(4).700-702.
7.朱应文,陈书忠.补阳还五汤治疗中风后遗症期病人的血液流变学观察(附150例报告)[J].哈尔滨医药,2005,(6).98-102.
8.韩峭立.中西医结合治疗缺血性脑血管病32例临床分析[J].实用中西医结合临床,2005,(6).37-37.
9.贾永忠.补阳还五汤加味治疗脑梗死疗效观察[J].山西中医,2005,(6).23-36.
10.罗卫东,李力.补阳还五汤治疗中风后遗症150例疗效观察[J].中医药学报,2005,(5).49-49.
11.柯锋,吴洪,邓春龄,吴民献,蔡柏,万诚,曾坤全,方林彬.补阳还五汤对气虚血瘀型和非气虚血瘀型缺血性中风病人的疗效比较[J].中西医结合心脑血管病杂志,2005,(11).962-963.
12.吴基良,刘超.补阳还五汤对大鼠局灶性脑缺血再灌注损伤的保护作用[J].中国老年学杂志,2004,(6).551-553.
13.文志斌,尚改萍,何晓凡,熊石龙,汉建忠,刘发益,周春生,肖振军,李俊成,贺石林.补阳还五汤对凝血酶诱导血管内皮细胞释放NO,vWF,TFPI及表达组织因子的影响[J].湖南医科大学学报,2002,(4).551-553.
14.尚改萍,文志斌,李俊成,汉建忠,熊石龙,贺石林,肖振军,周春生.补阳还五汤对TNF-a诱导血管内皮细胞释放vWF及表达组织因子的影响[J].湖南医科大 学学报,2000,(2).129-131.
15.陈利国,屈援,葛红颖,胡小勤,聂优爱,何孟栖.补阳还五汤对血瘀证大鼠血管内皮细胞黏附分子表达的影响[J].中草药,2005,36(5).706-709.
16.谭锋.欧正武.补阳还五汤的钙拮抗作用对脑水肿细胞超微结构变化的影响[J].深圳中西医结合杂志,1997,7(2):25-26.
17.张运克.补阳还五汤拆方对脑缺血再灌注SD大鼠模型脑组织含水量及Ca2+含量的影响[J].中医药学刊,2003,21(11):1829-1830.
18.郭彦坤.补阳还五汤对局灶性脑缺血的保护作用,黑龙江中医药,2006,1,19
19.莫孙炼,郑有顺.补阳还五汤拆方对实验性脑缺血损伤大鼠脑组织皮层梗塞面积及血浆内皮素的影响[J].中药药理与临床,1997,23(1).56-59.
20.吴玉生,姜立萍.补阳还五汤对早期脑梗塞患者内皮素、降钙素基因相关肽的影响[J].中药药理与临床,1998,15(2).4-7.
21.张运克.补阳还五汤及拆方对脑缺血再灌注模型大鼠血清及脑组织超氧化物歧化酶及丙二醛和一氧化氮含量的影响(英文)[J].中国临床康复,2005,(9).366-369.
22.蔡冬梅,殷胜利,吴伟康.补阳还五汤治疗气虚血瘀型冠心病的临床疗效及血浆中NO含量的改变[J].现代医学,2004,40(1).25-28.
23.陈秀芳,张玲,李丽仕.补阳还五汤提取物对脑缺血再灌流后一氧化氮合酶活性的影响[J].卒中与神经疾病,2001,9(2).288-289.
24.张红宇,高菊珍,张晓华.补阳还五汤对气虚血瘀证大鼠血液流变学的影响[J].云南中医学院学报,2000,(3).10.
25.赵玉霞,楚中华,孔令钧.补阳还五汤对中风患者血小板及纤溶活性的影响[J],山东中医杂志,2001,20(5),336.
26.张继平,张玉萍,文凤妮,等.补阳还五汤对大鼠静脉血栓形成前后静脉血中血小板活化因子含量的影响[j],中国实验方剂学杂志,1998,4(5),18.
27.高兆录,司毅,贺景宏,补阳还五汤合用维生素(对急性脑梗死患者自由基及血液流变性的影响[j],中国中西医结合急救杂志,2000,7(1):57.
28.刘志龙,邓常青,葛金文,等.补阳还五汤对兔脑缺血再灌注损伤)TXA2/PGI2、环核苷酸及钙的影响[j],中医药理与临床,1996,12(4):5.
29.毛小平,谢忠明.补阳还五汤提取物对家兔高胆固醇血症和血液流变性影响的实验研究[J],微循环学杂志,2001,11(4):19.
30.高颖,蔡定芳.大脑中动脉阻塞大鼠MMP9基因表达及补阳还五汤对其影响保护作用,中成药,2003,25(7):560-562.
31.赖真,王沙燕,耿小茵,张阮章,段晓慧,邓常青.补阳还五汤和黄芪对沙土鼠脑缺血再灌注后脑组织兴奋性氨基酸的影响[J].北京中医药大学学报,2002,(3).
32.Erecinska M,Silver IA.ATP and brain function[J].J Cereb Blood Flo wMetab,1989,9(1):2-19.
33.刘志龙,宋含平,邓常青,等.补阳还五汤对沙鼠脑缺血损伤细胞凋亡的影响及机理研究[J].广州中医药大学学报,2000,17(4):318-319.
34.邓常青,邓奕晖,向华林,贺福元,唐映红.补阳还五汤及其有效部位对沙鼠脑缺血后DND脑能量代谢、NO和NOS的影响[J].中药药理与临床,1999,(5).3.
35.张运克,魏明,宰军华.补阳还五汤及拆方对脑缺血再灌注模型血清、脑组织的SOD、MDA及NO含量影响[J].中药新药与临床药理,2003,14(6):366-359.
36.邢三丽,李振华,孙晋浩,刘岳鹏,暴丽华.补阳还五汤提取液对Schwann细胞氧化损伤的保护作用[J].神经解剖学杂志,2006,(1).95-98.
37.邢三丽,李振华,孙晋浩,刘岳鹏,暴丽华.补阳还五汤的抗氧化作用[J].解剖学杂志,2005,(5).529-531
38.郭平,王浩,王晶.补阳还五汤对实验性脑缺血再灌注损伤抗氧化作用的研究[J].山东中医杂志,2001,20(10).621-623.
39.胥显民,陈显久,补阳还五汤对大鼠全血比粘度、TXB2、LPO和SOD的影响[J],山西医科大学学报,2002,33(3),212-214.
40.Lipton SA,Resenberg PA.Mechanisms of disease:excitatory amino acids as a final common pathway for neurologic disorders[J].N Engl J Med,1994,330:613-625.
41.吴基良,刘超.补阳还五汤对大鼠局灶性脑缺血再灌注损伤的保护作用[J].中国老年学杂志,2004,26(6).10-12.
42.耿小茵,赖真,邓常青,等.补阳还五汤对鼠脑缺血再灌注后脑组织兴奋性氨基酸的作用[J].广州中医药大学学报,2004,21(2):125-127.
43.邓常青,邓奕晖,贺福元等.补阳还五汤和有效部位组方对沙土鼠脑缺血及再灌注后脑组织EAA的影响[J].中国实验方剂学杂志,2001,7(6):24-27.
44.Hangai.M et al.Inducible Nitric Oxide Synthase in Retinal Ischemia-ReperfusionInjury[j].Exp Eye Res,1996,63(5):501-509.
45.郭平,王晶,王浩.补阳还五汤抗脑缺血再灌注损伤作用机理的研究[J].中药药理与临床,2001,17(2).3-4.
46.廖春来,佟丽,陈育尧.补阳还五汤对脑缺血大鼠nNOS免疫阳性神经元的影响[J].第一军医大学学报,2004,24(8):864-366.
47.Mlainskit.Bailey F.Zhang ZG.Et al.Nitric oxide measured by a porphyrinic mic rosensor in rat brain after transient middle cerebral aftery occlusion[J].J Cereb Blood Flow Metab,1993,13:355-390.
48.Sato s.et al.Role of Nitric Oxide in brain ischemia[j],Ann NY Aca Sci,1994,738:369-374.
49.刘志龙,宋含平,邓常青,韩绍娟.补阳还五汤对沙土鼠脑缺血损伤能量代谢的影响[J].中国中西医结合急救杂志,2001,8(1).36-37.
50.Feuerstein GZ,Liu T,Barone FC.Cytokines inflammatin and brain injury:role of tumornecrosi s factora.Cerebrovase Brain Metab Rev,1994,6:3417-3422.
51.Chopp M,li jing N.Antibodis against adhesion molecule reduce apoptosis after transient cerebral middle artery occlusion rat brain.Jcereb Blood Flow Metab,1996,16:578-567.
52.毛小平,唐尊立,段申汉.白细胞浸润及脑梗死体积的影响,卒中与神经疾病,2002,9(5),288-291.
53.韩绍娟,刘志龙.补阳还五汤对沙土鼠脑缺血再灌注损伤后血清炎性细胞因子IL-1β、IL-6、TNF-α的影响[J].实用中西医结合临床,2004,(4).1-3.
54.成细华,邓奕辉,梅志刚,丁志高,喻嵘,田道法.补阳还五汤对缺氧-复氧内皮细胞ICAM-1 mRNA表达影响的研究[J].湖南中医学院学报,2004,(2).4-6.
55.Reynold BA,Weiss S.Generation of neu tons and astrocytes from isolated cells of the adult mammalian central nervous system[J].Science,1992,255(5052):1707-1711.
56.孙晋浩,杨琳,高英茂,李振华,底秀敏.补阳还五汤对神经干细胞生长分化的影响[J].山东大学学报(医学版),2002,40(5).406-408.
57.刘柏炎,蔡光先,林琳,曾序求,丁志高.补阳还五汤对大鼠局灶性脑缺血后神经干细胞影响的初步研究[J].中国临床康复,2004,(22).4532-4533.
58.刘柏炎,蔡光先.补阳还五汤对低糖低氧损伤神经干细胞移行分化的影响[J].中 国药物与临床,2005,5(3).171-173.
59.蔡光先,刘柏炎.补阳还五汤对体外低糖低氧损伤海马神经干细胞增殖的影响[J].湖南中医学院学报,2005,25(2).1-3.
60.吕晓红,许丽艳,李恩民,等.一氧化氮在迟发性神经元坏死中与程序性细胞死亡关系的研究[J],中风与神经疾病杂志,1997,2(1),68-71.
61.钱叶斌,陶有略,黄翠芬,武一曼.补阳还五汤促进周围神经损伤后神经元存活的实验研究.实用手外科杂志.2002,12(3),152-156.
62.刘志龙,宋含平.补阳还五汤对沙土鼠脑缺血损伤细胞凋亡影响及机理的研究[J],广州中医药大学学报,2000,17(4),318-321.
63.邓常青,贺福元.补阳还五汤及其有效部位组方对沙士鼠脑缺血再灌注后海马*A%区超微结构的影响6'8,中药药理与临床,2000,16(3),7-9.
64.彭力宏,李翠屏,郑吉民.补阳还五汤含药血清对体外培养大鼠皮层神经元缺氧凋亡的影响[J],广州中医药大学学报,2002,19(3),207-210.
65.曲宏达.补阳还五汤药物血清对体外培养大鼠皮层神经元缺氧后p53和p21表达的影响,中国中西医结合杂志,2002,24(3),133-135.
66.王新高,童萼塘,孙圣刚.补阳还五汤对脑缺血再灌注大鼠皮质神经细胞凋亡的影响[J].中国比较医学杂志,2005,15(6),363-367.
67.彭康,孙忠.补阳还五汤对中风后遗症“气虚血瘀”大鼠脑组织三磷酸腺苷及二磷酸腺苷和单胺类神经递质的影响,中医康复研究,2004,8(10),1908-1911.
68.韩东,廖福龙,李文,等.补阳还五汤及拆方对血栓形成大鼠梗塞灶、血管损伤平暗区、血浆t-PA,PAI活性及ET含量的影响[J]中国实验方剂学杂志,2001,7(2):21-24.
69.林桂涛,尹宁宁,马承严,等.应用均匀设计筛选补阳还五汤处方[J].中药材,1997,7(7):364-365.
70.姚晖,吴勇杰,张继平,陈芝喜,李志强,陈津岩,何赞厚.补阳还五汤体外对家兔血小板PAF受体活性影响的拆方研究[J].新中医,2005,(12).82-84.
71.张振强,张运克.补阳还五汤对脑缺血再灌注大鼠血浆TXB_2、6-keto-PGF_1a含量的影响[J].河南大学学报(医学科学版),2004,(3).9-11.
72.张运克,魏明,宰军华.补阳还五汤及拆方对脑缺血再灌注模型血清、脑组织的SOD、MDA及NO含量影响[J].中药新药与临床药理,2003,14(6):366-369.
1.Tuszynki mh.Neurotrophic factor[A].Tuszynski MH,Koedower J.CNAS tegeneration [M].San diego:Academic Press,1999,109-158.
2.Chen ZY,Caol,Wang LM,etal.Devolopment of neurotrothic factor for tretment of nueuodegeneration[J].Curr Protein Pep Sci,2001,2(3):261-276.
3.KrekoskI BV.Isolation and characterization of nerve growth factor(NGF) excreted from caltured eukaryotic cells.J Nat Toxims.2001:10(3):213-219.
4.Hantzopoulos PA,Suri C,Glass DJ,et al.The low affinity,NGF receptor,P75,can collaborate with each of the Trks to potentiate functional responses to the neurotrophins.Neuron.1994:13(1):187-201.
5.Roux PP,Barker PA.Neurotrophin signaling through the p75 neu-rotrophin receptor.Prog Neurobiol,2002,67:203-233.
6.Walton M,Connor B,Lawlor P,et al.Neuronal death and survival in two models of hypoxic-ischemic brain damage.Brain Res Brain Res Rev,1999,29:137-168.
7.Ballarin M,Ernfors P,Lindefore N.Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain[J].Exp Neurol,1991,114(1):35-43.
8.8.Du J,Feng L,Yang F,et al.Activity and Ca2+ dependent modulation of surface expression of brain-derived neurotrophic factor.Receptors in hippocampal neurous[J].J Cell Boil,2000,150(6):1423-1434.
9.Kenneth P,Madden MD.Effect of gamma r-aminobutyric acid modulation on neuronal ischemia in rabbits.Stroke,1994,25(11):2271-2275.
10.王良斌,吴馥梅.神经生长因子对小鼠海马突触体内[Ca2+]的影响[J].上海第二医科大学学报,2000,20(1),9-11.
11.张建国,张颖,王忠诚,栾国明,宋咏梅,王丽.代谢性损害对培养的海马神经元形态结构和Ca2+含量的影响[J].中华神经外科杂志,1999,15(6):368-370.
12.林凌,张鹤云,顾海明,汤国枝,张祖暄,张维宁,陈荣三.神经生长因子在培养的皮质神经细胞中抑制谷氨酸毒性[J].中国药理学报,1996,(3).
13.Cheng B,Mattson MP.NT-3 and BDNF protect CNS neurous against metabolic excitotoxic insults[J].Brain Res,1994,640(122):56-67.
14.Rocha M,Martins RA,Linden R.Activation of NMDA receptors protects against glutamate neurotoxicity in the retina:evidence for the involvement of neurotrophins [J].BrainRes,1999,827(122):79-92.
15.吴俊芳,张均田.神经生长因子对谷氨酸及过氧化氢介导的新生大鼠脑细胞内游离钙浓度升高的影响(英)[J].Journal of Chinese Pharmaceutical Sciences,1999,(1).
16.Faleiro L,Kobayashi R,Fearnhead H etal.Multiple species of CPP-32 and Mch2 are the major active caspase present in apoptotic cells.EMBOJ,1997,16:2271-2281.
17.金大成,王铁民,方秀斌.CGRP和NGF对短暂性全脑缺血后再灌注大鼠纹皮质Caspase-3蛋白表达的影响[J].神经解剖学杂志,2004,(3).254-260.
18.Enari M,Sakahira H,Yokoyama H et al.Acaspase-activated D Nase that degrades DNA during apoptosis,and its inhibitor ICAD.Nature,1998;391:43-50.
19.秦建兵,毛伟峰,金国华,田美玲,张毅,徐慧君.大鼠创伤性脑损伤后神经元的凋亡及NOS、NGF-R、bcl-2、ChAT阳性神经元的变化[J].交通医学,2003,(5).30-33.
20.Hee Han B,Dc CostaA,Back SA,et al.BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia[J].Neurobiol Dis,2000,7(1):38-53.
21.Sinson G,Perri BR,Troyanowsli JQ,et al.Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death following neurotrophin infusion after experimental traumatic brain injury[J].J Neurosurg,1997,86(3):511-518.
22.KiprianovaI,Feiman TM,Desiderato S,et al.Brain-derived neurotrophie factor prevents neuronal death and glial activation after global ischemia in the rat[J].J Neurosei Res,1999,56(1):21-27.
23.徐正冬,李贯菲.BDNF,NGF在大鼠局灶性脑缺血的表达变化及葛根素对其影响的实验研究.中国实验诊断学.2005,9(4),578-580.
24.王佩,齐浩波,乔占涛,王淑敏.李育臣局灶脑缺血大鼠脑源性神经营养因子及其受体的表达.中西医结合心脑血管病学杂志.2003,1(3),138-140.
25.钟相根,李澎涛,王永炎.清开灵有效组分对缺血脑组织神经营养因子含量的影响.北京中医药大学学报.2004,27(3),21-25.
26.徐正冬,李贯菲.BDNF,NGF在大鼠局灶性脑缺血的表达变化及葛根素对其影响的实验研究.中国实验诊断学.2005,9(4),578-580.
27.李育臣,董玉娟,王建茹,王冰.银杏叶提取物对脑缺血大鼠脑源性神经营养因子的影响.中风与神经疾病杂志.2005,22(1),55-57.
28.刘昌云,车春晖,黄华品.银杏内酯对大鼠局灶脑缺血再灌注后皮质脑源性神经营养因子(BDNF)表达的影响.海峡药学.2005,17(6),51-55.
29.卢宏,王建平,李昕,张苏明,方思羽.雌二醇对大鼠脑缺血/再灌注损伤脑组织BDNF表达的影响.郑州大学学报(医学版).2005,40,1,47-49.
30.王占军,陆兵勋,姬仲.氟西汀预处理对大鼠脑缺血再灌注海马区BDNF和bcl-2表达的影响.中国微侵袭神经外科医学杂志.2005,10(9),414-416.
31.刘昌云,陈龙飞,许国英,等.亚低温对局灶性脑缺血再灌注大鼠脑皮质脑源性神经营养因子表达及神经元凋亡的影响.中国现代神经疾病杂志.2005,5(6),338-341.
32.徐巳奕,包映晖,江基尧.神经营养因子与血脑屏障的研究进展[J].中华神经医学杂志,2005,(1).92-94.